IBDEI205 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,33970,1,4,0)
 ;;=4^D75.89
 ;;^UTILITY(U,$J,358.3,33970,2)
 ;;=^5002392
 ;;^UTILITY(U,$J,358.3,33971,0)
 ;;=D47.Z9^^131^1680^173
 ;;^UTILITY(U,$J,358.3,33971,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33971,1,3,0)
 ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior,Other
 ;;^UTILITY(U,$J,358.3,33971,1,4,0)
 ;;=4^D47.Z9
 ;;^UTILITY(U,$J,358.3,33971,2)
 ;;=^5002262
 ;;^UTILITY(U,$J,358.3,33972,0)
 ;;=D05.82^^131^1680^34
 ;;^UTILITY(U,$J,358.3,33972,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33972,1,3,0)
 ;;=3^Carcinoma in Situ Left Breast,Other Spec Type
 ;;^UTILITY(U,$J,358.3,33972,1,4,0)
 ;;=4^D05.82
 ;;^UTILITY(U,$J,358.3,33972,2)
 ;;=^5001934
 ;;^UTILITY(U,$J,358.3,33973,0)
 ;;=D05.81^^131^1680^36
 ;;^UTILITY(U,$J,358.3,33973,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33973,1,3,0)
 ;;=3^Carcinoma in Situ Right Breast,Oth Spec Type
 ;;^UTILITY(U,$J,358.3,33973,1,4,0)
 ;;=4^D05.81
 ;;^UTILITY(U,$J,358.3,33973,2)
 ;;=^5001933
 ;;^UTILITY(U,$J,358.3,33974,0)
 ;;=D05.80^^131^1680^38
 ;;^UTILITY(U,$J,358.3,33974,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33974,1,3,0)
 ;;=3^Carcinoma in Situ Unspec Breast,Oth Spec Type
 ;;^UTILITY(U,$J,358.3,33974,1,4,0)
 ;;=4^D05.80
 ;;^UTILITY(U,$J,358.3,33974,2)
 ;;=^5001932
 ;;^UTILITY(U,$J,358.3,33975,0)
 ;;=D56.8^^131^1680^186
 ;;^UTILITY(U,$J,358.3,33975,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33975,1,3,0)
 ;;=3^Thalassemias,Other
 ;;^UTILITY(U,$J,358.3,33975,1,4,0)
 ;;=4^D56.8
 ;;^UTILITY(U,$J,358.3,33975,2)
 ;;=^5002305
 ;;^UTILITY(U,$J,358.3,33976,0)
 ;;=C82.89^^131^1680^76
 ;;^UTILITY(U,$J,358.3,33976,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33976,1,3,0)
 ;;=3^Follicular Lymphoma,Extranodal/Solid Organ Sites,Other Types
 ;;^UTILITY(U,$J,358.3,33976,1,4,0)
 ;;=4^C82.89
 ;;^UTILITY(U,$J,358.3,33976,2)
 ;;=^5001540
 ;;^UTILITY(U,$J,358.3,33977,0)
 ;;=D51.8^^131^1680^193
 ;;^UTILITY(U,$J,358.3,33977,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33977,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemias,Other
 ;;^UTILITY(U,$J,358.3,33977,1,4,0)
 ;;=4^D51.8
 ;;^UTILITY(U,$J,358.3,33977,2)
 ;;=^5002288
 ;;^UTILITY(U,$J,358.3,33978,0)
 ;;=I80.9^^131^1680^178
 ;;^UTILITY(U,$J,358.3,33978,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33978,1,3,0)
 ;;=3^Phlebitis/Thrombophlebitis,Unspec Site
 ;;^UTILITY(U,$J,358.3,33978,1,4,0)
 ;;=4^I80.9
 ;;^UTILITY(U,$J,358.3,33978,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,33979,0)
 ;;=D45.^^131^1680^179
 ;;^UTILITY(U,$J,358.3,33979,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33979,1,3,0)
 ;;=3^Polycythemia Vera
 ;;^UTILITY(U,$J,358.3,33979,1,4,0)
 ;;=4^D45.
 ;;^UTILITY(U,$J,358.3,33979,2)
 ;;=^96105
 ;;^UTILITY(U,$J,358.3,33980,0)
 ;;=C77.3^^131^1680^109
 ;;^UTILITY(U,$J,358.3,33980,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33980,1,3,0)
 ;;=3^Malig Neop Axilla/Upper Limb Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,33980,1,4,0)
 ;;=4^C77.3
 ;;^UTILITY(U,$J,358.3,33980,2)
 ;;=^5001330
 ;;^UTILITY(U,$J,358.3,33981,0)
 ;;=C77.2^^131^1680^125
 ;;^UTILITY(U,$J,358.3,33981,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33981,1,3,0)
 ;;=3^Malig Neop Intra-Abdominal Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,33981,1,4,0)
 ;;=4^C77.2
 ;;^UTILITY(U,$J,358.3,33981,2)
 ;;=^267316
 ;;^UTILITY(U,$J,358.3,33982,0)
 ;;=C77.1^^131^1680^126
 ;;^UTILITY(U,$J,358.3,33982,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33982,1,3,0)
 ;;=3^Malig Neop Intrathoracic Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,33982,1,4,0)
 ;;=4^C77.1
 ;;^UTILITY(U,$J,358.3,33982,2)
 ;;=^267315
 ;;^UTILITY(U,$J,358.3,33983,0)
 ;;=C77.0^^131^1680^142
